Show simple item record

dc.contributor.authorLee, S.
dc.contributor.authorHammond, T.
dc.contributor.authorWatson, M.
dc.contributor.authorFlexman, J.
dc.contributor.authorCheng, W.
dc.contributor.authorFernandez, S.
dc.contributor.authorPrice, Patricia
dc.date.accessioned2017-01-30T10:41:48Z
dc.date.available2017-01-30T10:41:48Z
dc.date.created2016-09-12T08:36:57Z
dc.date.issued2010
dc.identifier.citationLee, S. and Hammond, T. and Watson, M. and Flexman, J. and Cheng, W. and Fernandez, S. and Price, P. 2010. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-a and ribavirin therapy?. Clinical and Experimental Immunology. 161 (1): pp. 118-126.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/4814
dc.identifier.doi10.1111/j.1365-2249.2010.04141.x
dc.description.abstract

The proportions and activation status of T cells may influence responses to hepatitis C virus (HCV) and treatment outcome in patients receiving pegylated interferon (IFN)-a/ribavirin therapy. We confirmed that IFN-? enzyme-linked immunospot (ELISPOT) responses to HCV are poor in HCV patients and showed that responses to HCV and cytomegalovirus (CMV) antigens decrease during therapy. This was most apparent in patients with sustained virological response (SVR). Baseline frequencies of CD4+ effector memory (TEM) T cells were lower in SVR than non-SVR. Proportions of CD4+ and CD8+ TEM and terminally differentiated effector memory (TEMRA) T cells declined on therapy in SVR, as did proportions of Fas+ CD8+ TEMRA T cells. Baseline frequencies of programmed death (PD)-1-expressing CD4+ TEM and T EMRA T-cells were higher in SVR. Therapy increased percentages of PD-1+ CD4+ central memory (TCM) T cells and PD-1+ CD8+ TEM and TEMRA T cells in SVR. We conclude that successful therapy depletes circulating antigen-specific CD4+ T cell responses. This paralleled decreases in proportions of effector memory T cells and higher percentages of CD4+ TCM T cells expressing PD-1. © 2010 British Society for Immunology.

dc.titleCould a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-a and ribavirin therapy?
dc.typeJournal Article
dcterms.source.volume161
dcterms.source.number1
dcterms.source.startPage118
dcterms.source.endPage126
dcterms.source.issn0009-9104
dcterms.source.titleClinical and Experimental Immunology
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusOpen access via publisher


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record